Morphometric evaluation of paraneoplastic neuropathies associated with carcinomas, lymphomas, and dysproteinemias

Journal of the Peripheral Nervous System

Volumn 3, Issue 4, 1998, Pages 259-266

  Wang, Jian Feng ^a,c   Schröder, J Michael ^a,b  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c DALIAN MUNICIPAL CENTRAL HOSPITAL   (China)

Author keywords

Axon; Dysproteinemia; Lymphoma; Morphometry; Myelin sheath; Paraneoplastic neuropathy; Sural nerve

Indexed keywords

ADULT; ARTICLE; CARCINOMA; CONTROLLED STUDY; CRYOGLOBULINEMIA; DISEASE SEVERITY; DYSPROTEINEMIA; HUMAN; HUMAN TISSUE; LUNG SMALL CELL CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MORPHOMETRICS; MYELIN SHEATH; MYELINATED NERVE; MYELOMA; PARANEOPLASTIC SYNDROME; PARAPROTEINEMIA; PERIPHERAL NEUROPATHY; POLYCYTHEMIA VERA; PRIORITY JOURNAL; SURAL NERVE; WALDENSTROEM MACROGLOBULINEMIA;

BLOOD PROTEIN DISORDERS; CARCINOMA; HUMANS; LYMPHOMA; MIDDLE AGED; PARANEOPLASTIC POLYNEUROPATHY; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; PERIPHERAL NERVOUS SYSTEM DISEASES; SENSATION DISORDERS;

EID: 0031757297     PISSN: 10859489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Harris W: Neuritis and Neuralgia. London, Oxford University Press 1926; p. 38.
2. Weber FP, Hill TR: Complete degeneration of the posterior columns of the spinal cord with chronic polyneuritis in a case of widespread carcinomatous disease elsewhere. J. Neurol. Psychopathol. 1933; 14:57-68.
3. Denny-Brown D: Primary sensory neuropathy with muscular changes associated with carcinoma. J. Neurol. Neurosurg. Psychiatry 1948; 11:73-87.
4. Dodgson MC, Hoffman HL: Sensory neuropathy associated with carcinoma of the esophagus. Report of a case. Ann. Intern. Med. 1953; 38:230-238.
5. Barron KD, Rowland LP, Zimmerman HM: Neuropathy with malignant tumor metastases. J. Nerv. Ment. Dis. 1960; 131:16-31.
6. Croft PB, Wilkinson M: Carcinomatous neuromyopathy. Its incidence in patients with carcinoma of the lung and carcinoma of the breast. Lancet 1963; 1:184-188.
7. Croft PB, Wilkinson M: The incidence of carcinomatous neuromyopathy in patients with various types of carcinoma. Brain 1965; 88:427-434.
8. Croft PB, Henson RA, Urich H, Wilkinson PC: Sensory neuropathy with bronchial carcinoma; a study of four cases showing serological abnormalities. Brain 1965; 88:501-514.
9. Henson RA, Hoffman HL, Urich H: Encephalomyelitis with carcinoma. Brain 1965; 88: 449-464.
10. Croft PB, Urich H, Wilkinson M: Peripheral neuropathy of sensorimotor type associated with malignant disease. Brain 1967; 90:31-71.
11. Henson RA, Urich H: Peripheral neuropathy associated with malignant disease. In: Handbook of Clinical Neurology, Vol. 8. Diseases of nerves, Part 2 (Vinken PJ, and Bruyn GW, eds). New York: American Elsevier, 1970, 131-146.
12. Henson RA, Urich H: Cancer and the nervous system. Oxford: Blackwell, Scientific Publications 1982.
13. Young KB, Thomas PK, King RHM: The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia. Comparative clinical, immunological and nerve biopsy findings. J. Neurol. 1991; 238:383-391.
14. Gosselin S, Kyle RA, Dyck PJ: Neuropathy associated with monoclonal gammopathies of undetermined significance. Ann. Neurol. 1991; 30:54-61.
15. Posner JB: Paraneoplastic syndromes. Neurol. Clin. 1991; 9:919-936.
16. Posner JB: Pathogenesis of central nervous system paraneoplastic syndromes. Rev. Neurol. 1992; 148:502-512.
17. Gemignani F, Pavesi G, Fiocchi A: Peripheral neuroapthy in essential mixed cryoglobulinaemia. J. Neurol. Neurosurg. Psychiatry 1992; 55:116-120.
18. Kyle RA: Monoclonal proteins in neuropathy. Neurol. Clin. 1992; 10:713-734.
19. Vrethem M, Cruz M, Huang WX: Clinical, neurophysiological, and immunological evdence of polyneuropathy in patients with monoclonal gammopthies. J. Neurol. Sci. 1993; 114:193-199.
20. Plante-Bordeneuve V, Baudrimont M, Gorin NC, Gherardi RK: Subacute sensory neuropathy associated with Hodgkin's disease. J. Neurol. Sci. 1994; 121:155-158.
21. Posner JB, Dalmau J: Clinical enigmas of paraneoplastic neurologic disorders. Clin. Neurol. Neurosurg. 1995; 97:61-70.
22. Graus F and Delattre JY: Immune modulation of paraneoplastic neurologic disorders. Clin. Neurol. Neurosurg. 1995; 97:112-116.
23. Thomas PK, DN Landon, RHM King: Pathological changes in specific neuropathies. In: Greenfield's Neuropathology (David I Graham and Peter L Lantos, eds) Sixth edition 1997, 455-463.
24. Lin SH, Ohnishi A, Jian XM, Yamamoto T: Clinical and pathological studies on peripheral neuropathy of six Chinese patients with lung cancer: morphometric evaluation of the sural nerve on biopsy. Sangyo Ika Daigaku Zasshi 1993; 15:13-20.
25. Wondrusch E, Zifko U, Grisold W, Drlicek M, Setinek U: Neuromuscular disorders in systemic malignancy and its treatment. Muscle Nerve 1996; 10:1362-1363.
26. McLeod JG: Paraneoplastic neuropathies. In: Peripheral Neuropathy, 3rd edition (Dyck PJ, Thomas PK, et al., eds). Philadelphia: WB Saunders, 1993, 1583-1598.
27. Moll JWB, Antoine JC, Brashear HR: Guidelines on the detection of paraneoplastic anti-neuronal-specific antibodies. Neurology (Minneap.) 1995; 45:1937-1941.
28. Midroni G, Bilbao JM: Neuropathy Associated with Neoplasia. In: Biopsy Diagnosis of Peripheral Neuropathy (Midroni G, Bilbao JM and Cohen SM, eds). Boston, Oxford: Butterrworth-Heinemann, 1995, 299-312.
29. Baya B, Frank M: T-cell mediated autoimmunity in the pathogenesis of anti-Hu associated paraneoplastic encephalomyelitis (PEM) and subacute sensory neuronopathy (PSN). Am. Acad. Neurol., 49th Annual Meeting Program 1997; 48:A32.
30. Dropcho EJ: Neurologic paraneoplastic syndromes. J. Neurol. Sci. 1998; 153:264-278.
31. Anderson NE, Rosenblum MK, Graus F: Autoantibodies in paraneoplastic syndromes associated with small cell lung cancer. Neurology (Minneap.) 1988; 38: 1391-1398.
32. Anderson NE: Anti-neuronal autoantibodies and neurological paraneoplasiec syndromes. Aust. N.Z.J. Med. 1989; 19:379-386.
33. Vital A, Vital C, Julien J: Polyneuropathy associated with IgM monoclonal gammopathy: immunological and pathological study in 31 patients. Acta Neuropathol. (Berl.) 1989; 79:160-167.
34. Monaco S, Bometti B, Ferrari S: Complement-mediated demyelination in patients with IgM monoclonal gammopathy and polyneuropathy. New Engl. J. Med. 1990; 322:649-652.
35. Nobile-Orazio E, Barbieri S, Baldini L: Peripheral neuropathy in monoclonal gammopathy of undetermined significance: prevalence and immunopathogenetic studies. Acta Neurol. Scand. 1992; 85:383-390.
36. Dalmau J, Graus F, Rosenblum MK: Anti Hu-associated paraneoplateic encephalo-myelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine 1992; 71:59-72.
37. Jean WC, Dalmau J, Ho A, Posner JB: Analysis of the IgG subclass distribution and inflammatory infiltrates in patients with anti-Hu-associated paraneoplastic encephalomyelitis. Neurology (Minneap.) 1994; 44:140-147.
38. Moll JWB, Vecht ChJ: Immune diagnosis of paraneoplastic neurological disease. Clin. Neurol. Neurosurg. 1995; 97:71-81.
39. Posner JB: Anti-Hu autoantibody associated sensory neuropathy/encephalomyelitis: a model of paraneoplastic syndrome. Perspect Bilo. Med. 1995; 38:167-181.
40. Dalmau J, Graus F, Cheung N-KV: Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer. Cancer 1995; 75:99-109.
41. Francesce R, Graus F: Western blot (WB) analysis of neuronal Hu antigens: distinct specificity of anti-Hu antibodies (HuAb) of small cell lung cancer (SCLC) in patients with or without paraneoplastic neurologic disorders (PND). Am. Acad. Neurol., 49th Annual Meeting Program 1997; 48:A32.
42. Schröder JM, Krämer KG, Hopf HC: Granular nuclear inclusion body disease: fine structure of tibial muscle and sural nerve. Muscle Nerve 1985; 8:52-59.
43. Schröder JM, May R, Shin YS, Sigmund M: Juvenile hereditary polyglucosan body disease with complete branching enzyme deficiency (type IV glycogenosis). Acta Neuropathol. (Berl.) 1993; 85:419-430.
44. Schröder JM, Sommer C: Mitochondrial abnormalities in human sural nerves: fine structural evaluation of cases with mitochondrial myopathy, hereditary and non-hereditary neuropathies, and review of the literature. Acta Neuropathol. (Berl.) 1991; 82:471-482.
45. Behse F: Morphometric studies on the human sural nerve. Acta Neurol. Scand. 1990; 82(Suppl. 132):1-38.
46. Jacobs JM, Love S: Qualitative and quantitative morphology of human sural nerve at different ages. Brain 1985; 108:897-924.
47. Costa G, Holland JF: Systemic effect of tumors with special reference to the nervous system. In Brain, Lord and Norris FH: The remote effects of cancer on the nervous system. New York, Grune & Stratton 1965; 125-142.
48. Barron SA, Heffner RR: Weakness in malignancy: Evidence for a remote effect of tumor on distal axons. Ann. Neurol. 1978; 4:268-274.
49. Posner JB: Pathogenesis of central nervous system paraneoplastic syndromes. Rev. Neurol. 1992; 148:502-512.
50. Tohgi H, Tsukagoshi H, Toyokura Y: Quantitative changes with aging in normal sural nerves. Acta Neuropathol. (Berl.) 1977; 38:213-220.
51. Midroni G, Bilbao JM: Quantitative Techniques. In: Biopsy Diagnosis of Peripheral Neuropathy (Midroni G, Bilbao JM and Cohen SM, eds). Boston, Oxford: Butterworth-Heinemann, 1995, 35-43.
52. Schröder JM, Bohl J, Brodda K: Changes of the ratio between myelin thickness and axon diameter in the human development sural nerve. Acta Neuropathol. (Berl.) 1978; 43:169-178.
53. Schröder JM, Bohl J, Bardeleben U: Changes of the ratio between myelin thickness and axon diameter in the human developing sural nerve, femoral, ulnar, facial and trochlear nerves. Acta Neuropathol. (Berl.) 1988; 74:471-483.
54. Schröder JM: Paraneoplastic neuropathy. In: Neuropathologie (Peiffer J, Schröder JM, eds). Berlin, Heidelberg, New York: Springer, 1995, 395-399.
55. Schlaepfer WW: Axonal degeneration in the sural nerves of cancer patients. Cancer 1974; 34:371-381.
56. Lamarche J, Vital C: Carcinomatous neuropathy. An ultrastructural study of 10 cases. Ann. Pathol. 1987; 7:98-105.